Self-assembled nanoparticles
present unique properties that have
potential applications in the development of a successful drug delivery
system. Doxorubicin (DOX) is an important anti-neoplastic anthracycline
chemotherapeutic drug widely described. However, it suffers from serious
dose-dependent cardiotoxicity. d-Limonene is a major constituent
of numerous citrus oils that is considered a specific monoterpene
against free radicals producing antioxidant activity. Herein, we aimed
to design three types of self-assembled nanodelivery systems (nanoemulsion,
niosomes, and polylactide nanoparticles) for loading both DOX and d-limonene to enhance the solubilization of d-limonene
and provide antioxidant activity with excellent anticancer activity.
As confirmed by dynamic light scattering and transmission electron
microscopy, the nanoparticles were prepared successfully with diameter
sizes of 52, 180, and 257 nm for the DOX-loaded nanoemulsion, niosomes,
and polylactide nanoparticles, respectively. The zeta potential values
were above −30 mV in all cases, which confirms the formation
of stable nanoparticles. The loading efficiency of DOX was the highest
in the case of the DOX-loaded nanoemulsion (75.8%), followed by niosomes
(62.8%), and the least was in the case of polylactide nanoparticles
with a percentage of 50.2%. The in vitro release study of the DOX-loaded
nanoparticles showed a sustained release profile of doxorubicin with
the highest release in the case of DOX-loaded PDLLA nanoparticles.
The kinetic release model for all developed nanoparticles was the
Peppas–Sahlin model, demonstrating DOX release through Fickian
diffusion phenomena. Moreover, all developed nanoparticles maintain
the antioxidant activity of d-limonene. The cytotoxicity
study of the DOX-loaded nanoparticles showed concentration-dependent
anticancer activity with excellent anticancer activity in the case
of the DOX-loaded nanoemulsion and polylactide nanoparticles. These
nanoparticles will be further studied in vivo to prove the cardioprotective
effect of d-limonene in combination with DOX.